Skip to main content
Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.8520
+0.0070 (0.83%)
At close: May 9, 2025, 4:00 PM
0.8983
+0.0463 (5.43%)
After-hours: May 9, 2025, 4:50 PM EDT

Citius Oncology Stock Forecast

CTOR's stock price has decreased by -92.38% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Citius Oncology stock have an average target of 4.50, with a low estimate of 3.00 and a high estimate of 6.00. The average target predicts an increase of 428.17% from the current stock price of 0.85.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $3.00 $4.50 $6.00 $6.00
Change +252.11% +428.17% +604.23% +604.23%
* Price targets were last updated on Nov 27, 2024.

Analyst Ratings

The average analyst rating for Citius Oncology stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Mar '25Apr '25May '25
Strong Buy 222
Buy 000
Hold 000
Sell 000
Strong Sell 000
Total 222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Michael Okunewitch
Maxim Group
 Maxim Group
Strong Buy
Initiates
$3
 Strong Buy Initiates $3 +252.11% Nov 27, 2024
Jason Kolbert
EF Hutton
 EF Hutton
Strong Buy
Maintains
$6
 Strong Buy Maintains $6 +604.23% Aug 13, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 106.16M
Revenue Next Year
n/a
EPS This Year
-0.24
from -0.31
EPS Next Year
-0.03
from -0.24
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Sep 30, 2022 Sep 30, 2023 Sep 30, 2024 Sep 30, 2025 Sep 30, 2026 Sep 30, 2027
Revenue
 29.26M74.34M106.16M
Revenue Growth
 -154.11%42.80%---
EPS
 -0.32-0.19-0.31-0.24-0.030.44
EPS Growth
 ------
Forward PE
 -----1.94
No. Analysts
 ---333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High 30.1M 76.5M 109.3M
Avg 29.3M 74.3M 106.2M
Low 28.1M 71.4M 102.0M

Revenue Growth

Revenue Growth 202520262027
High
-71.6%
161.6%
47.0%
Avg
-72.4%
154.1%
42.8%
Low
-73.5%
144.1%
37.2%

EPS Forecast

EPS 202520262027
High -0.25 -0.03 0.45
Avg -0.24 -0.03 0.44
Low -0.24 -0.03 0.42

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.